Injecting new life: How to fill the gaping hole in support for R&D intensive businesses at late-stage funding
Vaccine breakthrough proves anything is possible
Moray Wright of Parkwalk Advisors
This week's rollout of the Oxford-AstraZeneca vaccine has shone a spotlight on the importance of research & development (R&D) in tackling the greatest challenges faced by humanity. It is a knowledge-intensive businesses whose years of work goes on to underpin the greatest leaps in mankind.
For example, anyone who saw the BBC Panorama programme "The Race for a Vaccine" will know the science behind the Oxford-AstraZeneca vaccine came from years of deep technological work on ways to adapt viruses...
More on Industry
Back to Top
